Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG
( DrugBank: Dextromethorphan, Dextromethorphan hydrobromide, Quinidine, Quinidine sulfate / KEGG DRUG: Dextromethorphan hydrobromide, Dextromethorphan, Daunorubicin, Dextromethorphan hydrobromide, Dextromethorphan, Daunorubicin, Quinidine gluconate, Quinidine polygalacturonate, Quinidine sulfate, Quinidine, Quinidine gluconate, Quinidine polygalacturonate, Quinidine sulfate, Quinidine )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
2 | Amyotrophic lateral sclerosis | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis | 1 |
2. Amyotrophic lateral sclerosis
Clinical trials : 786 / Drugs : 550 - (DrugBank : 182) / Drug target genes : 170 - Drug target pathways : 232
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
13. Multiple sclerosis
Clinical trials : 3,685 / Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|